Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University)(Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University))

概要

基本信息

药物类型

血液提取物

别名-

靶点-

作用方式-

作用机制-

治疗领域

免疫系统疾病眼部疾病其他疾病

在研适应症

慢性移植物抗宿主病干燥综合征性角膜结膜炎

非在研适应症-

原研机构

Pavlov First Saint Petersburg State Medical University

在研机构

Pavlov First Saint Petersburg State Medical University

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University) 相关的临床试验

NCT05311514

/ Completed临床2期IIT

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Keratoconjunctivitis Sicca Resistant to Traditional Therapy in Patients With Chronic Ocular Graft-versus-host After Allogeneic Hematopoietic Stem Cell Transplantation.

The study evaluates the efficacy and safety of allogeneic platelet lysate eye drops in patients with severe ocular graft versus host disease refractory to conventional systemic and local treatments. The corneal staining, conjunctival hyperemia, tear film break up time,Schirmer test and ocular surface disease index will be evaluated before and after allogeneic platelet lysate treatment. The safety of allogeneic platelet lysate treatment will be also assessed.

开始日期2021-04-01

申办/合作机构

Pavlov First Saint Petersburg State Medical University

100 项与 Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University) 相关的临床结果

登录后查看更多信息

100 项与 Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University) 相关的转化医学

登录后查看更多信息

100 项与 Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University) 相关的专利（医药）

登录后查看更多信息

100 项与 Allogeneic platelet lysate(Pavlov First Saint Petersburg State Medical University) 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
慢性移植物抗宿主病	临床2期	俄罗斯	Pavlov First Saint Petersburg State Medical University	2021-04-01
干燥综合征性角膜结膜炎	临床2期	俄罗斯	Pavlov First Saint Petersburg State Medical University	2021-04-01